RAIN - Rain Oncology GAAP EPS of -$0.19 beats by $0.06 November, 09 2023 05:40 PM Rain Therapeutics Inc. 2023-11-09 17:40:19 ET Rain Oncology press release ( NASDAQ: RAIN ): Q3 GAAP EPS of -$0.19 beats by $0.06 . As of September 30, 2023, Rain had $77.3 million in cash, cash equivalents and short-term investments. For further details see: Rain Oncology GAAP EPS of -$0.19 beats by $0.06